Alveolar Cleft Reconstruction With Cortical-Shells

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-15
SponsorBeni-Suef University

About this trial

The main goal of the secondary alveolar bone grafting (SABG) for alveolar clefts is the rehabilitation of the disorganized maxilla, aiming to stabilize the maxillary foundation as a solid functional mass that would abort growth disturbance, allow for teeth eruption, and enhance their orthodontic movements.

The study evaluates the outcomes of a ( SABG) technique that utilizes the retromolar cortical shell technique to reconstruct the alveolar clefts.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients of both sexes with an age range of (eight to fifteen years), with unilateral maxillary alveolar cleft.

good oral hygiene and general good health

Disqualifiers

The evidence of clinical or radiographic signs of local maxillary pathosis or palatal fistulae.

Those patients with bilateral alveolar clefts, cleft-associated syndromes, and those with a systemic disease that would affect either bone harvest or graft healing.

A history of previous failed alveolar cleft reconstruction.

Trial design

Design model

Single group

Treatments tested in this trial

  • Cortical-shell graft

    Procedure/Surgery

    Retromolar cortical shell graft technique for SABG

Treatment groups

7 Participants
are divided into 1 treatment group
Group A: Secondary alveolar bone grafting (SBAG)Other 1 intervention

Trial outcomes

Primary outcomes

1

Horizontal bone width

The amplitude of radiographic horizontal bone width change

Time frame
6 months consolidation period

Secondary outcomes

1

Vertical bone level

The amplitude of radiographic vertical bone change

Time frame
6 months consolidation period
2

Bone density

The radiographic bone density of the consolidated graft at the site of the reconstructed cleft

Time frame
6 months consolidation period

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.